Yahoo Web Search

Search results

1. • BRIEF-Kyorin Holdings Inc, Sumitomo Pharma - Entered Into License Agreement Of Vibegron In Taiwan...

     Reuters SG via Yahoo Singapore Finance· 1 year ago

     March 6 (Reuters) - Kyorin Holdings Inc and Sumitomo Pharma Co Ltd: * ENTERED INTO LICENSE AGREEMENT OF VIBEGRON IN TAIWAN AND OTHER ASIAN COUNTRIES Source text for Eikon: Further company coverage:

2. • 

     Data breach at medical giant Cencora exposes info from multiple drug companies

     TechRadar via Yahoo News Singapore· 1 month ago

     Healthcare. Almost a dozen pharmaceutical companies, including several major players, have lost...

3. • 

     Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study

     Benzinga via Yahoo Singapore Finance· 3 months ago

     Tuesday, Roivant Sciences (NASDAQ:ROIV) and Priovant Therapeutics announced results from the Phase 2...

4. • Q1 2024 Exscientia PLC Earnings Call

     Thomson Reuters StreetEvents via Yahoo Singapore Finance· 1 month ago

     Participants Chin Okeke; IR; Exscientia PLC Dave Hallett; Interim CEO, Chief Scientific Officer; Exscientia PLC Ben Taylor; CFO, Chief Strategy Officer; Exscientia PLC Alec Stranahan; Analyst ...

5. • UPDATE 1-Roivant's anti-inflammatory drug succeeds in mid-stage study

     Reuters via Yahoo Singapore Finance· 3 months ago

     Roivant Sciences said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's ...

6. • Japan's Nikkei rounds off 2023 with biggest yearly gain in a decade

     Reuters via Yahoo Singapore Finance· 6 months ago

     Japan's Nikkei share average closed 2023 with its best year in a decade on expectations of better governance, though ticking lower in the day's session amid a lack of any big triggers. On Friday ...

7. • Japan's Nikkei slips after Fed chair signals delay in rate cut

     Reuters via Yahoo Singapore Finance· 5 months ago

     Japan's Nikkei share average fell on Thursday, after U.S. Federal Reserve chair Jerome Powell's comments doused hopes of a possible interest rate cut in March. The Nikkei tumbled 0.72% to 36,024.29 ...